![These highlights do not include all the information needed to use Adapalene safely and effectively.See full prescribing information for Adapalene Gel, 0.3%. Adapalene Gel, 0.3% For topical use only Initial U.S. Approval: These highlights do not include all the information needed to use Adapalene safely and effectively.See full prescribing information for Adapalene Gel, 0.3%. Adapalene Gel, 0.3% For topical use only Initial U.S. Approval:](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=P52322-1+45g+PUMP+carton.jpg&id=308198)
These highlights do not include all the information needed to use Adapalene safely and effectively.See full prescribing information for Adapalene Gel, 0.3%. Adapalene Gel, 0.3% For topical use only Initial U.S. Approval:
![These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE Gel for topical use Initial U.S. Approval: 1996 These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE Gel for topical use Initial U.S. Approval: 1996](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=container.jpg&id=711627)
These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE Gel for topical use Initial U.S. Approval: 1996
![Adapalene-Benzoyl Peroxide Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD Adapalene-Benzoyl Peroxide Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD](https://img.medscapestatic.com/pi/features/drugdirectory/octupdate/GLN03010.jpg)
Adapalene-Benzoyl Peroxide Topical: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
![Galderma Laboratories Receives FDA Approval for New Convenient Pump Dispenser of Differin(R) Gel, 0.3% for Treatment of Acne Vulgaris | BioSpace Galderma Laboratories Receives FDA Approval for New Convenient Pump Dispenser of Differin(R) Gel, 0.3% for Treatment of Acne Vulgaris | BioSpace](http://media.marketwire.com/attachments/201203/TN-41316_DIFFERINPUMPv2.jpg)
Galderma Laboratories Receives FDA Approval for New Convenient Pump Dispenser of Differin(R) Gel, 0.3% for Treatment of Acne Vulgaris | BioSpace
![PDF] Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. | Semantic Scholar PDF] Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/09de7eae99b9b251975f053fd7b9c33cb860edd1/7-Figure3-1.png)
PDF] Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. | Semantic Scholar
![These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE Gel for topical use Initial U.S. Approval: 1996 These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE Gel for topical use Initial U.S. Approval: 1996](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=cont-45g.jpg&id=711627)
These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE Gel for topical use Initial U.S. Approval: 1996
![These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE gel, for topical use Initial U.S. Approval: 1996 These highlights do not include all the information needed to use ADAPALENE GEL safely and effectively. See full prescribing information for ADAPALENE GEL. ADAPALENE gel, for topical use Initial U.S. Approval: 1996](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-2.jpg&id=663603)